share_log

U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy

U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy

U.K. 's 大衛·納特教授被評爲世界頂級心理藥理學家:更多關於他的貢獻和倡導的信息
Benzinga ·  2023/10/16 08:06

Professor David Nutt, a cognitive sciences, addiction, cannabis and psychedelics researcher, has been ranked the #1 psychopharmacologist by ScholarGPS, a California-based American company owned and operated by Meta Analytics LLC.

認知科學、成癮、大麻和迷幻藥研究員大衛·納特教授被Meta Analytics LLC旗下和運營的總部位於加利福尼亞的美國公司ScholarGPS評爲 #1 心理藥理學家。

According to the platform's definition, Highly Ranked Scholars are "the most productive authors whose works are of profound impact and of utmost quality," identified within each specialty, discipline and field, according to lifetime or prior five-year activity.

根據該平台的定義,排名靠前的學者是根據終身或之前五年的活動在每個專業、學科和領域中確定的 “生產力最高的作者,其作品具有深遠影響力和最高質量”。

The platform recognized Prof. Nutt's work in the fields of brain and cognitive sciences, addiction, anxiety and social sciences.

該平台認可了納特教授在大腦和認知科學、成癮、焦慮和社會科學領域的工作。

Nutt's contributions exceed over 1000 original research papers, reviews and book chapters, 27 books and eight government reports on drugs. He was the editor of the Journal of Psychopharmacology for two decades and a government advisor in the U.K. and U.S. as well as the research director for several institutions worldwide.

納特的貢獻超過了1000多篇原創研究論文、評論和書籍章節、27本書和8份關於毒品的政府報告。他曾擔任《心理藥理學雜誌》的編輯二十年,在英國和美國擔任政府顧問,並擔任全球多家機構的研究主任。

He founded and is chair of the national nonprofit Drug Science, formally the Independent Scientific Committee on Drugs (ISCD), president of the European Brain Council and Edmond J. Safra chair in neuropsychopharmacology and director of the neuropsychopharmacology unit in the brain sciences division at Imperial College London.

他創立了全國非營利組織 “藥物科學”(前身爲獨立藥物科學委員會(ISCD)),並擔任其主席,歐洲大腦委員會主席和倫敦帝國理工學院腦科學系神經心理藥理學系神經心理藥理學系主任埃德蒙·薩夫拉神經心理藥理學系主任。

In the private business sphere, Nutt currently serves as Chief Research Officer (CRO) at Awakn Life Sciences (OTC:AWKNF).

在私營企業領域,納特目前在Awakn Life Sciences(場外交易代碼:AWKNF)擔任首席研究官(CRO)。

He previously presided over the European College of Neuropsychopharmacology (ECNP), the British Neuroscience Association (BNA) and the British Association of Psychopharmacology (BAP), and is a Fellow of the Royal Colleges of Physicians and of Psychiatrists and a Fellow of the Academy of Medical Sciences.

他曾任歐洲神經心理藥理學會(ECNP)、英國神經科學協會(BNA)和英國心理藥理學協會(BAP)的主席,並且是皇家內科醫學院和精神科醫生學院院士和醫學科學院院士。

And yet he has also made himself available for general public broadcast both on radio, TV and lectures at such events as the Psychedelic Science, Cheltenham Science Festival, Café Scientifiques.

然而,他還公開接受了廣播、電視以及迷幻科學、切爾滕納姆科學節、Cafeé Scientifiques等活動的講座。

(See latest interview with Prof. Nutt by The Dales Report on the future of mental health.)

(查看《戴爾斯報告》對納特教授關於心理健康未來的最新採訪。)

Photo courtesy of Wikimedia Commons.

照片由維基共享資源提供。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論